ruxolitinib

Vitiligo Treatment from the Iron Age to the Age of Biologics: New Hope for an Ancient Disease

December 2023

Dr. Harris presented an overview of past and present treatments for vitiligo, including advances in vitiligo research and ongoing work to improve vitiligo treatment in the future. First, Dr. Harris described research that led to FDA approval of topical ruxolitinib for vitiligo. Dr. Harris sought to develop targeted immunotherapies that could treat vitiligo while avoiding…

JAK Inhibitor Therapy for Alopecia Areata

December 2023

Dr. Aguh presented about alopecia areata (AA) and treatment with JAK inhibitors. First, Dr. Aguh described AA and the categories of disease severity. Common subtypes of AA include patch, totalis, and universalis; additional subtypes include ophiasis, incognito, and canitis subita, which manifests as sudden graying of the hair. She described that fortunately, most patients have…

New Topical Therapies for Psoriasis and Atopic Dermatitis

December 2022

Dr. Bhutani presented new topical therapies for psoriasis and atopic dermatitis, including tapinarof, roflumilast, and ruxolitinib.

Topics